A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

NCT07201129 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Nephritis, Lupus
Lupus Erythematosus, Systemic

Interventions

DRUG: Cenerimod
DRUG: Placebo

Sponsor

Viatris Innovation GmbH